MEDS (DataMEDS AI) Short-Term Debt: $15.35 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is DataMEDS AI Short-Term Debt?

DataMEDS AI MEDS -3.35% Short-Term Debt is $15.35 Mil as of Mar. 2026. The stock has 6 warning signs investors should review.

DataMEDS AI's Short-Term Debt for the quarter that ended in Mar. 2026 was $15.35 Mil.

DataMEDS AI's quarterly Short-Term Debt declined from Sep. 2025 ($12.44 Mil) to Dec. 2025 ($11.07 Mil) but then increased from Dec. 2025 ($11.07 Mil) to Mar. 2026 ($15.35 Mil).

DataMEDS AI's annual Short-Term Debt increased from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($12.04 Mil) but then declined from Dec. 2024 ($12.04 Mil) to Dec. 2025 ($11.07 Mil).

DataMEDS AI Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

DataMEDS AI Short-Term Debt Related Terms

DataMEDS AI Short-Term Debt Historical Data

* Premium members only.

The historical data trend for DataMEDS AI's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DataMEDS AI Short-Term Debt Chart

DataMEDS AI Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Short-Term Debt
0.00 0.00 12.04 11.07

DataMEDS AI Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.85 13.40 12.44 11.07 15.35
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $15.35 Mil mean?
DataMEDS AI (MEDS) has a Short-Term Debt of $15.35 Mil as of Mar. 2026.
Is DataMEDS AI's Short-Term Debt too high?
DataMEDS AI's current Short-Term Debt is $15.35 Mil.
How does DataMEDS AI's Short-Term Debt compare to HEWA and BLMH?
DataMEDS AI's Short-Term Debt of $15.35 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Distribution company?
A good Short-Term Debt depends on the Medical Distribution industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. DataMEDS AI's current Short-Term Debt is $15.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DataMEDS AI stock overvalued right now?
DataMEDS AI (MEDS) has a current Short-Term Debt of $15.35 Mil. The current Short-Term Debt is $15.35 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For DataMEDS AI (MEDS), the current Short-Term Debt is $15.35 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DataMEDS AI Business Description

Address 3000 Bayport Drive, Suite 950, Tampa, FL, USA, 33607
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. The company seeks to be a micro health ecosystem, with a portfolio comprising a pharmacy, wholesale operations, and a technology division that provides a novel platform for hub and clinical services. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.